Print Page | Close Window

Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

Recent Press Releases

October 20, 2017 - 8:03 a.m.
Gilead Announces Multiple Scientific Presentations Demonstrating High Cure Rates in Difficult-to-Cure HCV Patients and Improved Long-Term Bone and Renal Safety of Vemlidy® in HBV Patients Switched from Viread®Printer Friendly Version 
October 18, 2017 - 5:44 p.m.
Kite’s Yescarta™ (Axicabtagene Ciloleucel) Becomes First CAR T Therapy Approved by the FDA for the Treatment of Adult Patients With Relapsed or Refractory Large B-Cell Lymphoma After Two or More Lines of Systemic TherapyPrinter Friendly Version 

Upcoming Events

Friday, October 20, 2017 through Tuesday, October 24, 2017
The Liver Meeting 2017
LocationWashington, DC
Wednesday, October 25, 2017 through Friday, October 27, 2017
16th European AIDS Conference
LocationMilan, Italy
Thursday, October 26, 2017 4:30 p.m. ET
Third Quarter 2017 Gilead Sciences Earnings Conference Call
Friday, November 3, 2017 through Wednesday, November 8, 2017
American College of Rheumatology Annual Meeting
LocationAmerican College of Rheumatology Annual Meeting
San Diego, California

Most Viewed Links

Updated 10/21/17
1.SEC Filings
2.Annual Reports
3.Investor Contact
4.Stock Information
* Data collected 10/13/17 - 10/20/17

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.